In a recent investigation, it was revealed that the U.S. Drug Enforcement Administration (DEA) permitted the distribution of large quantities of fentanyl in New Mexico. This decision was part of an effort to facilitate larger federal prosecutions, according to journalists Jim Mustian and Joshua Goodman from the Associated Press (AP). They examined extensive DEA records and spoke with current and former agents, including a whistleblower.
The White House identified fentanyl as a ‘weapon of mass destruction’ last year. The whistleblower’s complaint, first spotted by Goodman, alleged that the DEA allowed fentanyl to reach the streets of New Mexico. While the report sent to the White House was heavily redacted, a minor oversight in the redactions hinted at the whistleblower’s identity. This led to the discovery of David Howell, the whistleblower.
The DEA’s Approach to Drug Enforcement
The DEA’s historical practice of allowing drugs to ‘walk,’ aiming to catch more significant offenders, faces criticism when applied to fentanyl. This synthetic opioid’s potency is evident in the DEA’s ‘One Pill Can Kill’ campaign. It highlights that even a few milligrams can be fatal.
Counterfeit pills, often containing unknown amounts of fentanyl, are mainly produced by cartels in Mexico. A notable example from 2023 involved a fentanyl shipment observed, but not seized, at an Albuquerque mobile home park. Agents documented 74,000 pills delivered, sparking concerns amidst rising overdose deaths.
Federal officials defended their actions, arguing that such methods target more significant threats. Alex Uballez, the U.S. attorney in Albuquerque, explained that sometimes allowing drugs to reach their destination is necessary to target more substantial criminal activities. The DEA stated these actions were lawful and consistent with guidelines.
Insights from the Investigation
This story underscores a significant disconnect between law enforcement activities and public awareness. Federal agents wield considerable discretion affecting public safety, with many operations remaining out of public sight unless disclosed.
Howell’s whistleblower complaint provided crucial insight into internal DEA procedures and the Department of Justice’s adjustments to its rules. The whistleblower’s actions led to an investigation by the Office of Special Counsel (OSC), noting a ‘substantial likelihood of wrongdoing.’ However, the Justice Department eventually found the DEA’s decisions reasonable.
“In many instances, the government asks us to simply trust it’s doing the right thing.”
Howell reportedly submitted official communications and reports detailing transactions and decisions not to seize massive fentanyl quantities. While some investigations found the DEA’s actions justified, critics argue that these decisions allowed significant amounts of fentanyl to reach users.
The AP encourages tip submissions to their global investigative team through secure, confidential methods.